Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 19, 2017
Pharmacy Choice - Pharmaceutical News - Global Health Solutions Announces FDA Clearance of Novel, Non-Steroidal Topical Ointment for Atopic Dermatitis - September 19, 2017

Pharmacy News Article

 9/11/17 - Global Health Solutions Announces FDA Clearance of Novel, Non-Steroidal Topical Ointment for Atopic Dermatitis

By a News Reporter-Staff News Editor at Pharma Business Week Global Health Solutions, a Georgia based biotechnology company engaged in the development of novel, topical therapeutic agents for chronic wounds and dermatologic conditions, has announced FDA clearance of AtopX? Emulsion, indicated for the management of atopic, irritant, and radiation dermatitis. AtopX? employs Global Health Solutions' proprietary delivery technology, PermaFusion?, first showcased in its groundbreaking chronic wound care products (see also Global Health Solutions).

Atopic dermatitis, commonly known as eczema, is a chronic condition that affects nearly 18 million children and adults in the United States. Global Health Solutions' Founder and CEO, Bradley Burnam, states: "Eczema is a systemic condition. The goal of topical therapy in the management of eczema should focus entirely on symptom management and skin repair. AtopX? has shown dramatic effectiveness in early clinical results, along with a safety profile rivaling even over-the-counter options." Neil Ghodadra, MD, Global Health Solutions' Chief Medical Officer, discusses AtopX?: "Eczema is an incredibly pervasive, stubborn condition, with limited non-steroidal options. AtopX? will provide physicians a safe, cost-effective, topical solution that creates an ideal healing environment for injured tissue resulting from this systemic condition."

Global Health Solutions expects AtopX? to be well-received by practitioners and patients due to its ease of use, safety profile, and efficacy. AtopX? has been tested and certified non-sensitizing, non-irritating, and non-cytotoxic, providing a welcome option for the delicate skin of children, who are most commonly afflicted by atopic dermatitis.

Keywords for this news article include: Eczema, Pediatrics, Dermatology, Atopic Dermatitis, Global Health Solutions, Skin Diseases and Conditions, Skin and Connective Tissue Diseases and Conditions.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC



(c) 2017 NewsRx LLC

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 20: What's New? New Treatments for Type 2 Diabetes
Last Chance
Sep 21: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Sep 22: Influenza 2017-2018: An Update on Prevention and Treatment
Sep 24: Using Effective Communication to Reduce Medication Errors
Sep 25: Management of Major Depressive Disorders
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415